User: prashantiyengar Topic: IP
Category: patents :: india
Last updated: Apr 19 2017 08:04 IST RSS 2.0
 
1 to 20 of 5,907    
Prescribing generic medicines already a must under MCI rules 19.4.2017 TOI: India
While PM Modi has said that “legal arrangements“ will be made to make prescription of generic medicines compulsory, the fact is that this is already mandatory . The Medical Council of India's ethics code for docs made generic prescription mandatory in October 2016, though it has never been enforced.
Also found in: [+]
PM's push for generic drugs to shift focus to chemists, says pharma industry body 18.4.2017 ET: Pharma
Patients may end up with drugs that "may not be effective at all" if doctors were made to prescribe only generic medicines,, according to pharma industry body IPA.
Also found in: [+]
RSS-backed SJM declares 2017 'anti-China year' 14.4.2017 Rediff: Business
'I will be happy if walls are built between India and China!'
Also found in: [+]
Despite low-cost talent pool India not leveraging R&D 12.4.2017 Rediff: Top Stories (India)
Advantages are not being leveraged fully mainly because of lack of funds, say experts.
Also found in: [+]
About 2.5 lakh patent applications pending: Nirmala Sitharaman 5.4.2017 ET: Policy
Commerce and Industry Minister Nirmala Sitharaman also said that as on March 1, 2017, 7,53,471 trademark applications are pending at various stages of disposal.
Also found in: [+]
IPA punches holes into drug pricing policy implementation 4.4.2017 ET: Pharma
"This is not a good sign. It is indicative of trust deficit in the regulatory mechanism and administrative machinery, be it the NPPA or CDSCO," it added.
Also found in: [+]
Union HRD Minister Prakash Javadekar Releases ‘India Rankings 2017’ 3.4.2017 Govt of india: PIB
The Union Minister of Human Resource Development, Shri Prakash Javadekar , released the India Rankings 2017 for the Educational Institutions and dedicated it to the nation in New Delhi today. Speaking on the occasion he said that this step is a sequel of our Government’s commitment towards bringing
Also found in: [+]
Micromax introduces Dual 5 smartphone at Rs 24,999 30.3.2017 DNA: Top News
Homegrown handsets maker Micromax  announced a foray into premium devices with the launch of 4G smartphone Dual 5 priced at Rs 24,999. The company is also eyeing up to 25 per cent business growth during 2017-18.  "We want to be an important player in premium smartphone segment in Rs 20,000 plus range. All Micromax phones will now be 4G enabled. We expect 20-25 per cent business growth in 2017-18," Micromax Informatics Co-Founder Rahul Sharma said while launching the Dual 5. The new smartphone has a 13 MP dual rear camera with Sony sensors (one with colour and the other with monochrome sensor) and a 13 MP front facing camera. Dual 5 comes with Qualcomm Snapdragon processor, 4GB RAM, 128GB internal memory, Corning Gorilla Glass 3 and a 3,200mAh battery with quick charge feature. "Premium customers in the country need an option to buy something which is made in India, made for India and made by Indians. The Dual 5 will be made in India like our other phones," Sharma said. He said that the company will ...
Also found in: [+]
Mutt-funded Bengaluru lab develops life-saving product for soldiers 29.3.2017 TOI: Cities
A two-member team from the Centre for Incubation, Innovation, Research and Consultancy (CIIRC) at Jyothi Institute of Technology in south Bengaluru, which has received Rs 30 crore from Sringeri mutt, has applied for patent for a product that can stop bleeding in less than 90 seconds.
Also found in: [+]
Monsanto loses legal battle with Indian seed producer 28.3.2017 Sify Finance
NEW DELHI (Reuters) - Monsanto lost a legal battle with one of India's biggest seed producers over a contract dispute on Tuesday, and was ordered to restore a licensing agreement and cut royalty
Also found in: [+]
A lot to learn from IBM 27.3.2017 Financial Express: Front Page
Winning patents by the dozen is not what Indian companies are known for.
Also found in: [+]
`India–EFTA trade talks may adversely impact access to medicines in developing countries' 23.3.2017 TOI: India
Also found in: [+]
Post research, Mandyali Dham enters patent run 23.3.2017 TOI: Cities
Since ages traditional Dham (community feast) is an integral part of celebrations in Himachal Pradesh but for the first time scientists have found that Dham of Mandi district also known as "Mandyali Dham" is a complete food with ayurveda perspective and now efforts are being made to patent on it.
Also found in: [+]
Now, even Indian lawyers bank on Artificial Intelligence 21.3.2017 Rediff: Business
With the demand for lower costs in process driven activities and a move away from the high rate, billable hours of legal services, AI platforms are being used internationally in many legal tasks.
Also found in: [+]
NTPC installs India’s largest Floating Solar PV Plant in Kerala 10.3.2017 ET: Power
The system was installed by Swelect Energy Systems Ltd, Chennai with support from NETRA & NTPC Kayamkulam station in a short span of 22 days.
Also found in: [+]
NTPC installs India’s largest floating solar PV plant in Kerala 10.3.2017 ET: Power
Solar panels mounted on floating boards that hold them in place saves land usage and has been found to be efficient than the ones installed on land.
Also found in: [+]
Delhi HC dismisses Cipla's plea against single judge order 9.3.2017 ET: Pharma
The observation by the court came while dismissing Indian pharma company Cipla's bid to make and sell a generic version of Swiss drug major Novartis' patented respiratory disease medicine Indacaterol without a compulsory licence.
Also found in: [+]
Delhi High Court quashes Cipla's appeal, says it can't market generics of Novartis' Onbrez 9.3.2017 ET: Pharma
The court said it can't make a definitive conclusion that Novartis' imports of Onbrez were insufficient to meet the demands COPD patients from the data that was submitted by Cipla and Novartis during the hearings.
Also found in: [+]
Indian drug makers can export patented meds for approval: Delhi High Court 8.3.2017 ET: Pharma
Natco and Alembic, however, were directed to undertake that during the life of the respective patent, they will not export the respective patented invention for purposes other than those specified in section 107A.
Also found in: [+]
Delhi High Court favours Natco, Alembic; allows them to export generics of Bayer's drugs 8.3.2017 ET: Pharma
Bayer had approached court in 2016 to stop Alembic Pharmaceuticals from exporting its generic of the German company's blood thinner brand 'Xarelto' (Rivaroxaban), used to prevent and treat dangerous blood clots.
Also found in: [+]
1 to 20 of 5,907